tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:8F8 Stock Latest News

SynAct Pharma to Present at Redeye Autoimmune and Inflammatory Diseases Event
Company AnnouncementsSynAct Pharma to Present at Redeye Autoimmune and Inflammatory Diseases Event
6d ago
SynAct Pharma Advances Resomelagon Phase 2b Study for Rheumatoid Arthritis
PremiumCompany Announcements
SynAct Pharma Advances Resomelagon Phase 2b Study for Rheumatoid Arthritis
22d ago
SynAct Pharma to Engage in Strategic Discussions at BioEurope 2025
PremiumCompany Announcements
SynAct Pharma to Engage in Strategic Discussions at BioEurope 2025
25d ago
SynAct Pharma’s Q3 2025 Interim Report Highlights
PremiumCompany Announcements
SynAct Pharma’s Q3 2025 Interim Report Highlights
26d ago
SynAct Pharma AB Announces Extraordinary General Meeting to Discuss Key Resolutions
PremiumCompany Announcements
SynAct Pharma AB Announces Extraordinary General Meeting to Discuss Key Resolutions
27d ago
Edison Investment Research Initiates Coverage of SynAct Pharma
PremiumCompany AnnouncementsEdison Investment Research Initiates Coverage of SynAct Pharma
28d ago
SynAct Pharma’s AP1189 Study: A Potential Game-Changer in Rheumatoid Arthritis Treatment?
Premium
Company Announcements
SynAct Pharma’s AP1189 Study: A Potential Game-Changer in Rheumatoid Arthritis Treatment?
28d ago
8F8
SynAct Pharma’s AP1189 Study: A Potential Game-Changer in Nephrology
Premium
Company Announcements
SynAct Pharma’s AP1189 Study: A Potential Game-Changer in Nephrology
29d ago
8F8
SynAct Pharma Proposes Share Buy-Back to Boost Capital Structure
PremiumCompany Announcements
SynAct Pharma Proposes Share Buy-Back to Boost Capital Structure
2M ago
SynAct Pharma to Engage at Nordic Life Science Days 2025
PremiumCompany Announcements
SynAct Pharma to Engage at Nordic Life Science Days 2025
2M ago
SynAct Pharma’s CFO Departure Marks New Chapter in Strategic Development
PremiumCompany Announcements
SynAct Pharma’s CFO Departure Marks New Chapter in Strategic Development
2M ago
SynAct Pharma Enhances Shareholder Stability with Strategic Transactions
PremiumCompany Announcements
SynAct Pharma Enhances Shareholder Stability with Strategic Transactions
3M ago
SynAct Pharma Strengthens Leadership with New Chief Business Officer
PremiumCompany AnnouncementsSynAct Pharma Strengthens Leadership with New Chief Business Officer
3M ago
SynAct Pharma Expands Shares and Votes Following Warrant Conversion
Premium
Company Announcements
SynAct Pharma Expands Shares and Votes Following Warrant Conversion
3M ago
SynAct Pharma AB Releases Q2 2025 Interim Report
Premium
Company Announcements
SynAct Pharma AB Releases Q2 2025 Interim Report
3M ago
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
PremiumCompany Announcements
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
3M ago
SynAct Pharma Expands Share Base and Strengthens Financial Position
PremiumCompany Announcements
SynAct Pharma Expands Share Base and Strengthens Financial Position
4M ago
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
PremiumCompany Announcements
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
4M ago
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
PremiumCompany Announcements
SynAct Pharma Secures SEK 17.7 Million from Warrant Conversion
4M ago
SynAct Pharma’s Leadership Commits to Long-Term Growth with Lock-Up Agreements
PremiumCompany AnnouncementsSynAct Pharma’s Leadership Commits to Long-Term Growth with Lock-Up Agreements
5M ago
SynAct Pharma AB Announces Increase in Shares and Votes
Premium
Company Announcements
SynAct Pharma AB Announces Increase in Shares and Votes
5M ago
SynAct Pharma’s Leadership Shows Confidence with Share Acquisition
Premium
Company Announcements
SynAct Pharma’s Leadership Shows Confidence with Share Acquisition
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >